{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:21:09Z","timestamp":1767961269779,"version":"3.49.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2008,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Certain endogenous metabolites can influence the rate of cancer cell growth. For example, diacylglycerol, ceramides and sphingosine, NAD<jats:sup>+<\/jats:sup> and arginine exert this effect by acting as signaling molecules, while carrying out other important cellular functions. Metabolites can also be involved in the control of cell proliferation by directly regulating gene expression in ways that are signaling pathway-independent, e.g. by direct activation of transcription factors or by inducing epigenetic processes. The fact that metabolites can affect the cancer process on so many levels suggests that the change in concentration of some metabolites that occurs in cancer cells could have an active role in the progress of the disease.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>CoMet, a fully automated Computational Metabolomics method to predict changes in metabolite levels in cancer cells compared to normal references has been developed and applied to Jurkat T leukemia cells with the goal of testing the following hypothesis: <jats:italic>Up or down regulation in cancer cells of the expression of genes encoding for metabolic enzymes leads to changes in intracellular metabolite concentrations that contribute to disease progression<\/jats:italic>. All nine metabolites predicted to be lowered in Jurkat cells with respect to lymphoblasts that were examined (riboflavin, tryptamine, 3-sulfino-L-alanine, menaquinone, dehydroepiandrosterone, \u03b1-hydroxystearic acid, hydroxyacetone, seleno-L-methionine and 5,6-dimethylbenzimidazole), exhibited antiproliferative activity that has not been reported before, while only two (bilirubin and androsterone) of the eleven tested metabolites predicted to be increased or unchanged in Jurkat cells displayed significant antiproliferative activity.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>These results: a) demonstrate that CoMet is a valuable method to identify potential compounds for experimental validation, b) indicate that cancer cell metabolism may be regulated to reduce the intracellular concentration of certain antiproliferative metabolites, leading to uninhibited cellular growth and c) suggest that many other endogenous metabolites with important roles in carcinogenesis are awaiting discovery.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-7-57","type":"journal-article","created":{"date-parts":[[2008,6,17]],"date-time":"2008-06-17T18:13:27Z","timestamp":1213726407000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Identification of metabolites with anticancer properties by computational metabolomics"],"prefix":"10.1186","volume":"7","author":[{"given":"Adrian K","family":"Arakaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Mezencev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nathan J","family":"Bowen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John F","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Skolnick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,6,17]]},"reference":[{"key":"348_CR1","first-page":"319","volume":"152","author":"O Warburg","year":"1924","unstructured":"Warburg O, Posener K, Negelein E: Ueber den Stoffwechsel der Tumoren. Biochemische Zeitschrift. 1924, 152: 319-344.","journal-title":"Biochemische Zeitschrift"},{"issue":"1","key":"348_CR2","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.ccr.2006.10.020","volume":"11","author":"S Bonnet","year":"2007","unstructured":"Bonnet S, Archer SL, Allalunis-Turner J, Haromy A, Beaulieu C, Thompson R, Lee CT, Lopaschuk GD, Puttagunta L, Bonnet S, Harry G, Hashimoto K, Porter CJ, Andrade MA, Thebaud B, Michelakis ED: A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer cell. 2007, 11 (1): 37-51. 10.1016\/j.ccr.2006.10.020","journal-title":"Cancer cell"},{"issue":"1","key":"348_CR3","doi-asserted-by":"publisher","first-page":"77","DOI":"10.2174\/156800906775471734","volume":"6","author":"EP Araujo","year":"2006","unstructured":"Araujo EP, Carvalheira JB, Velloso LA: Disruption of metabolic pathways--perspectives for the treatment of cancer. Current cancer drug targets. 2006, 6 (1): 77-87. 10.2174\/156800906775471734","journal-title":"Current cancer drug targets"},{"issue":"4","key":"348_CR4","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrc2110","volume":"7","author":"EM Griner","year":"2007","unstructured":"Griner EM, Kazanietz MG: Protein kinase C and other diacylglycerol effectors in cancer. Nature reviews. 2007, 7 (4): 281-294. 10.1038\/nrc2110","journal-title":"Nature reviews"},{"issue":"23","key":"348_CR5","doi-asserted-by":"publisher","first-page":"5467","DOI":"10.1016\/j.febslet.2006.08.052","volume":"580","author":"B Ogretmen","year":"2006","unstructured":"Ogretmen B: Sphingolipids in cancer: regulation of pathogenesis and therapy. FEBS letters. 2006, 580 (23): 5467-5476. 10.1016\/j.febslet.2006.08.052","journal-title":"FEBS letters"},{"issue":"2","key":"348_CR6","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1042\/BJ20061638","volume":"402","author":"N Pollak","year":"2007","unstructured":"Pollak N, Dolle C, Ziegler M: The power to reduce: pyridine nucleotides--small molecules with a multitude of functions. The Biochemical journal. 2007, 402 (2): 205-218. 10.1042\/BJ20061638","journal-title":"The Biochemical journal"},{"issue":"4","key":"348_CR7","doi-asserted-by":"publisher","first-page":"E632","DOI":"10.1208\/aapsj080472","volume":"8","author":"T Yang","year":"2006","unstructured":"Yang T, Sauve AA: NAD metabolism and sirtuins: metabolic regulation of protein deacetylation in stress and toxicity. The AAPS journal. 2006, 8 (4): E632-43. 10.1208\/aapsj080472","journal-title":"The AAPS journal"},{"issue":"8","key":"348_CR8","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/sj.bjc.6603384","volume":"95","author":"N Ashraf","year":"2006","unstructured":"Ashraf N, Zino S, Macintyre A, Kingsmore D, Payne AP, George WD, Shiels PG: Altered sirtuin expression is associated with node-positive breast cancer. British journal of cancer. 2006, 95 (8): 1056-1061. 10.1038\/sj.bjc.6603384","journal-title":"British journal of cancer"},{"key":"348_CR9","first-page":"483","volume":"60","author":"W Grabon","year":"2006","unstructured":"Grabon W: [Arginine as a crucial amino acid in carcinogenesis and tumor growth]. Postepy higieny i medycyny doswiadczalnej (Online). 2006, 60: 483-489.","journal-title":"Postepy higieny i medycyny doswiadczalnej (Online)"},{"issue":"1","key":"348_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.molcel.2006.09.002","volume":"24","author":"AG Ladurner","year":"2006","unstructured":"Ladurner AG: Rheostat control of gene expression by metabolites. Molecular cell. 2006, 24 (1): 1-11. 10.1016\/j.molcel.2006.09.002","journal-title":"Molecular cell"},{"issue":"6","key":"348_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1021\/cb6002465","volume":"1","author":"DG Sashital","year":"2006","unstructured":"Sashital DG, Butcher SE: Flipping off the riboswitch: RNA structures that control gene expression. ACS chemical biology. 2006, 1 (6): 341-345. 10.1021\/cb6002465","journal-title":"ACS chemical biology"},{"issue":"5","key":"348_CR12","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1006\/scbi.2001.0389","volume":"11","author":"S Sommer","year":"2001","unstructured":"Sommer S, Fuqua SA: Estrogen receptor and breast cancer. Seminars in cancer biology. 2001, 11 (5): 339-352. 10.1006\/scbi.2001.0389","journal-title":"Seminars in cancer biology"},{"key":"348_CR13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/1476-4598-5-60","volume":"5","author":"M Ducasse","year":"2006","unstructured":"Ducasse M, Brown MA: Epigenetic aberrations and cancer. Molecular cancer. 2006, 5: 60- 10.1186\/1476-4598-5-60","journal-title":"Molecular cancer"},{"issue":"2","key":"348_CR14","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.molcel.2006.05.040","volume":"23","author":"H Takahashi","year":"2006","unstructured":"Takahashi H, McCaffery JM, Irizarry RA, Boeke JD: Nucleocytosolic acetyl-coenzyme a synthetase is required for histone acetylation and global transcription. Molecular cell. 2006, 23 (2): 207-217. 10.1016\/j.molcel.2006.05.040","journal-title":"Molecular cell"},{"issue":"10","key":"348_CR15","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1016\/j.chembiol.2006.08.008","volume":"13","author":"KP Chiang","year":"2006","unstructured":"Chiang KP, Niessen S, Saghatelian A, Cravatt BF: An enzyme that regulates ether lipid signaling pathways in cancer annotated by multidimensional profiling. Chemistry & biology. 2006, 13 (10): 1041-1050. 10.1016\/j.chembiol.2006.08.008","journal-title":"Chemistry & biology"},{"issue":"2","key":"348_CR16","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.imlet.2007.06.001","volume":"111","author":"M Zamanakou","year":"2007","unstructured":"Zamanakou M, Germenis AE, Karanikas V: Tumor immune escape mediated by indoleamine 2, 3-dioxygenase. Immunol Lett. 2007, 111 (2): 69-75. 2007\/07\/24, 10.1016\/j.imlet.2007.06.001","journal-title":"Immunol Lett"},{"issue":"3","key":"348_CR17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.critrevonc.2006.07.009","volume":"61","author":"UK Narta","year":"2007","unstructured":"Narta UK, Kanwar SS, Azmi W: Pharmacological and clinical evaluation of L-asparaginase in the treatment of leukemia. Critical reviews in oncology\/hematology. 2007, 61 (3): 208-221. 10.1016\/j.critrevonc.2006.07.009","journal-title":"Critical reviews in oncology\/hematology"},{"issue":"33","key":"348_CR18","doi-asserted-by":"publisher","first-page":"12505","DOI":"10.1073\/pnas.0605207103","volume":"103","author":"JE Ippolito","year":"2006","unstructured":"Ippolito JE, Merritt ME, Backhed F, Moulder KL, Mennerick S, Manchester JK, Gammon ST, Piwnica-Worms D, Gordon JI: Linkage between cellular communications, energy utilization, and proliferation in metastatic neuroendocrine cancers. Proceedings of the National Academy of Sciences of the United States of America. 2006, 103 (33): 12505-12510. 10.1073\/pnas.0605207103","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"6","key":"348_CR19","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1002\/mrm.21081","volume":"56","author":"G Reynolds","year":"2006","unstructured":"Reynolds G, Wilson M, Peet A, Arvanitis TN: An algorithm for the automated quantitation of metabolites in in vitro NMR signals. Magn Reson Med. 2006, 56 (6): 1211-1219. 10.1002\/mrm.21081","journal-title":"Magn Reson Med"},{"issue":"11","key":"348_CR20","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1002\/cbic.200500151","volume":"6","author":"EJ Want","year":"2005","unstructured":"Want EJ, Cravatt BF, Siuzdak G: The expanding role of mass spectrometry in metabolite profiling and characterization. Chembiochem. 2005, 6 (11): 1941-1951. 10.1002\/cbic.200500151","journal-title":"Chembiochem"},{"issue":"5","key":"348_CR21","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1002\/ijc.2910190505","volume":"19","author":"U Schneider","year":"1977","unstructured":"Schneider U, Schwenk HU, Bornkamm G: Characterization of EBV-genome negative \"null\" and \"T\" cell lines derived from children with acute lymphoblastic leukemia and leukemic transformed non-Hodgkin lymphoma. Int J Cancer. 1977, 19 (5): 621-626. 10.1002\/ijc.2910190505","journal-title":"Int J Cancer"},{"issue":"2","key":"348_CR22","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0145-2126(93)90062-P","volume":"17","author":"JD Cohen","year":"1993","unstructured":"Cohen JD, Robins HI, Katz TB, Miller EM, Kuzminsky SR, Javid MJ: Deoxyribonucleoside triphosphate pools and thymidine chemosensitization in human T-cell leukemia. Leukemia research. 1993, 17 (2): 167-174. 10.1016\/0145-2126(93)90062-P","journal-title":"Leukemia research"},{"issue":"1","key":"348_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1046\/j.0019-2805.2001.01340.x","volume":"105","author":"SG Harris","year":"2002","unstructured":"Harris SG, Phipps RP: Prostaglandin D-2, its metabolite 15-d-PGJ(2), and peroxisome proliferator activated receptor-gamma agonists induce apoptosis in transformed, but not normal, human T lineage cells. Immunology. 2002, 105 (1): 23-34. 10.1046\/j.0019-2805.2001.01340.x","journal-title":"Immunology"},{"issue":"23","key":"348_CR24","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1038\/sj.onc.1208530","volume":"24","author":"N Gao","year":"2005","unstructured":"Gao N, Rahmani M, Dent P, Grant S: 2-Methoxyestradiol-induced apoptosis in human leukemia cells proceeds through a reactive oxygen species and Akt-dependent process. Oncogene. 2005, 24 (23): 3797-3809. 10.1038\/sj.onc.1208530","journal-title":"Oncogene"},{"issue":"2-3","key":"348_CR25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0304-3835(94)90381-6","volume":"76","author":"MV Blagosklonny","year":"1994","unstructured":"Blagosklonny MV, Neckers LM: Cytostatic and cytotoxic activity of sex steroids against human leukemia cell lines. Cancer letters. 1994, 76 (2-3): 81-86. 10.1016\/0304-3835(94)90381-6","journal-title":"Cancer letters"},{"issue":"1","key":"348_CR26","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1472-8206.2005.00389.x","volume":"20","author":"M Buyukavci","year":"2006","unstructured":"Buyukavci M, Ozdemir O, Buck S, Stout M, Ravindranath Y, Savasan S: Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect. Fundam Clin Pharmacol. 2006, 20 (1): 73-79. 10.1111\/j.1472-8206.2005.00389.x","journal-title":"Fundam Clin Pharmacol"},{"issue":"1","key":"348_CR27","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ijc.21788","volume":"119","author":"B Kniep","year":"2006","unstructured":"Kniep B, Kniep E, Ozkucur N, Barz S, Bachmann M, Malisan F, Testi R, Rieber EP: 9-O-acetyl GD3 protects tumor cells from apoptosis. Int J Cancer. 2006, 119 (1): 67-73. 10.1002\/ijc.21788","journal-title":"Int J Cancer"},{"issue":"6","key":"348_CR28","doi-asserted-by":"crossref","first-page":"C1776","DOI":"10.1152\/ajpcell.2001.281.6.C1776","volume":"281","author":"TD Batiuk","year":"2001","unstructured":"Batiuk TD, Schnizlein-Bick C, Plotkin Z, Dagher PC: Guanine nucleosides and Jurkat cell death: roles of ATP depletion and accumulation of deoxyribonucleotides. American journal of physiology. 2001, 281 (6): C1776-84.","journal-title":"American journal of physiology"},{"issue":"4","key":"348_CR29","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1073\/pnas.76.4.1998","volume":"76","author":"EW Gelfand","year":"1979","unstructured":"Gelfand EW, Lee JJ, Dosch HM: Selective toxicity of purine deoxynucleosides for human lymphocyte growth and function. Proceedings of the National Academy of Sciences of the United States of America. 1979, 76 (4): 1998-2002. 10.1073\/pnas.76.4.1998","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"issue":"1-2","key":"348_CR30","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1023\/A:1021651811345","volume":"243","author":"J Saldeen","year":"2003","unstructured":"Saldeen J, Tillmar L, Karlsson E, Welsh N: Nicotinamide- and caspase-mediated inhibition of poly(ADP-ribose) polymerase are associated with p53-independent cell cycle (G2) arrest and apoptosis. Mol Cell Biochem. 2003, 243 (1-2): 113-122. 10.1023\/A:1021651811345","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"348_CR31","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/(SICI)1097-4644(20000501)77:2<333::AID-JCB15>3.0.CO;2-Q","volume":"77","author":"J Du","year":"2000","unstructured":"Du J, Suzuki H, Nagase F, Akhand AA, Yokoyama T, Miyata T, Kurokawa K, Nakashima I: Methylglyoxal induces apoptosis in Jurkat leukemia T cells by activating c-Jun N-terminal kinase. Journal of cellular biochemistry. 2000, 77 (2): 333-344. 10.1002\/(SICI)1097-4644(20000501)77:2<333::AID-JCB15>3.0.CO;2-Q","journal-title":"Journal of cellular biochemistry"},{"issue":"6","key":"348_CR32","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.clnu.2006.05.008","volume":"25","author":"M Fernanda Cury-Boaventura","year":"2006","unstructured":"Fernanda Cury-Boaventura M, Cristine Kanunfre C, Gorjao R, Martins de Lima T, Curi R: Mechanisms involved in Jurkat cell death induced by oleic and linoleic acids. Clinical nutrition (Edinburgh, Scotland). 2006, 25 (6): 1004-1014.","journal-title":"Clinical nutrition (Edinburgh, Scotland)"},{"issue":"2","key":"348_CR33","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/0008-8749(91)90274-F","volume":"135","author":"MC Wacholtz","year":"1991","unstructured":"Wacholtz MC, Minakuchi R, Lipsky PE: Characterization of the 3', 5'-cyclic adenosine monophosphate-mediated regulation of IL2 production by T cells and Jurkat cells. Cellular immunology. 1991, 135 (2): 285-298. 10.1016\/0008-8749(91)90274-F","journal-title":"Cellular immunology"},{"issue":"Database issue","key":"348_CR34","doi-asserted-by":"publisher","first-page":"D521","DOI":"10.1093\/nar\/gkl923","volume":"35","author":"DS Wishart","year":"2007","unstructured":"Wishart DS, Tzur D, Knox C, Eisner R, Guo AC, Young N, Cheng D, Jewell K, Arndt D, Sawhney S, Fung C, Nikolai L, Lewis M, Coutouly MA, Forsythe I, Tang P, Shrivastava S, Jeroncic K, Stothard P, Amegbey G, Block D, Hau DD, Wagner J, Miniaci J, Clements M, Gebremedhin M, Guo N, Zhang Y, Duggan GE, Macinnis GD, Weljie AM, Dowlatabadi R, Bamforth F, Clive D, Greiner R, Li L, Marrie T, Sykes BD, Vogel HJ, Querengesser L: HMDB: the Human Metabolome Database. Nucleic acids research. 2007, 35 (Database issue): D521-6. 10.1093\/nar\/gkl923","journal-title":"Nucleic acids research"},{"issue":"1","key":"348_CR35","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1002\/(SICI)1097-4652(199607)168:1<105::AID-JCP13>3.0.CO;2-6","volume":"168","author":"JO Hensold","year":"1996","unstructured":"Hensold JO, Barth D, Stratton CA: RNA polymerase II inhibitor, 5, 6-dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) causes erythroleukemic differentiation and transcriptional activation of erythroid genes. Journal of cellular physiology. 1996, 168 (1): 105-113. 10.1002\/(SICI)1097-4652(199607)168:1<105::AID-JCP13>3.0.CO;2-6","journal-title":"Journal of cellular physiology"},{"issue":"1","key":"348_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0304-3835(98)00342-5","volume":"137","author":"EL Paley","year":"1999","unstructured":"Paley EL: Tryptamine-mediated stabilization of tryptophanyl-tRNA synthetase in human cervical carcinoma cell line. Cancer letters. 1999, 137 (1): 1-7. 10.1016\/S0304-3835(98)00342-5","journal-title":"Cancer letters"},{"issue":"1","key":"348_CR37","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.bbrc.2003.12.066","volume":"314","author":"N Calonghi","year":"2004","unstructured":"Calonghi N, Cappadone C, Pagnotta E, Farruggia G, Buontempo F, Boga C, Brusa GL, Santucci MA, Masotti L: 9-Hydroxystearic acid upregulates p21(WAF1) in HT29 cancer cells. Biochem Biophys Res Commun. 2004, 314 (1): 138-142. 10.1016\/j.bbrc.2003.12.066","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"348_CR38","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1097\/00001813-200606000-00005","volume":"17","author":"E Pagnotta","year":"2006","unstructured":"Pagnotta E, Calonghi N, Boga C, Masotti L: N-methylformamide and 9-hydroxystearic acid: two anti-proliferative and differentiating agents with different modes of action in colon cancer cells. Anti-cancer drugs. 2006, 17 (5): 521-526. 10.1097\/00001813-200606000-00005","journal-title":"Anti-cancer drugs"},{"issue":"8","key":"348_CR39","doi-asserted-by":"publisher","first-page":"1596","DOI":"10.1194\/jlr.M400424-JLR200","volume":"46","author":"N Calonghi","year":"2005","unstructured":"Calonghi N, Cappadone C, Pagnotta E, Boga C, Bertucci C, Fiori J, Tasco G, Casadio R, Masotti L: Histone deacetylase 1: a target of 9-hydroxystearic acid in the inhibition of cell growth in human colon cancer. J Lipid Res. 2005, 46 (8): 1596-1603. 10.1194\/jlr.M400424-JLR200","journal-title":"J Lipid Res"},{"issue":"2","key":"348_CR40","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbrc.2006.02.008","volume":"342","author":"N Calonghi","year":"2006","unstructured":"Calonghi N, Pagnotta E, Parolin C, Tognoli C, Boga C, Masotti L: 9-Hydroxystearic acid interferes with EGF signalling in a human colon adenocarcinoma. Biochem Biophys Res Commun. 2006, 342 (2): 585-588. 10.1016\/j.bbrc.2006.02.008","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"348_CR41","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1038\/sj.leu.2402155","volume":"15","author":"K Miyazawa","year":"2001","unstructured":"Miyazawa K, Yaguchi M, Funato K, Gotoh A, Kawanishi Y, Nishizawa Y, Yuo A, Ohyashiki K: Apoptosis\/differentiation-inducing effects of vitamin K2 on HL-60 cells: dichotomous nature of vitamin K2 in leukemia cells. Leukemia. 2001, 15 (7): 1111-1117. 10.1038\/sj.leu.2402155","journal-title":"Leukemia"},{"key":"348_CR42","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1471-2105-8-13","volume":"8","author":"MA Stalteri","year":"2007","unstructured":"Stalteri MA, Harrison AP: Interpretation of multiple probe sets mapping to the same gene in Affymetrix GeneChips. BMC Bioinformatics. 2007, 8: 13- 10.1186\/1471-2105-8-13","journal-title":"BMC Bioinformatics"},{"key":"348_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1186\/1471-2105-6-214","volume":"6","author":"SO Zakharkin","year":"2005","unstructured":"Zakharkin SO, Kim K, Mehta T, Chen L, Barnes S, Scheirer KE, Parrish RS, Allison DB, Page GP: Sources of variation in Affymetrix microarray experiments. BMC Bioinformatics. 2005, 6: 214- 10.1186\/1471-2105-6-214","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"348_CR44","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/bib\/bbl007","volume":"7","author":"JM Lee","year":"2006","unstructured":"Lee JM, Gianchandani EP, Papin JA: Flux balance analysis in the era of metabolomics. Brief Bioinform. 2006, 7 (2): 140-150. 10.1093\/bib\/bbl007","journal-title":"Brief Bioinform"},{"issue":"6","key":"348_CR45","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1086\/430799","volume":"76","author":"G Sriram","year":"2005","unstructured":"Sriram G, Martinez JA, McCabe ER, Liao JC, Dipple KM: Single-gene disorders: what role could moonlighting enzymes play?. American journal of human genetics. 2005, 76 (6): 911-924. 10.1086\/430799","journal-title":"American journal of human genetics"},{"key":"348_CR46","unstructured":"KEGG: Kyoto Encyclopedia of Genes and Genomes. ftp:\/\/ftp.genome.jp\/pub\/kegg\/"},{"issue":"21","key":"348_CR47","doi-asserted-by":"publisher","first-page":"6226","DOI":"10.1093\/nar\/gkh956","volume":"32","author":"W Tian","year":"2004","unstructured":"Tian W, Arakaki AK, Skolnick J: EFICAz: a comprehensive approach for accurate genome-scale enzyme function inference. Nucleic acids research. 2004, 32 (21): 6226-6239. 10.1093\/nar\/gkh956","journal-title":"Nucleic acids research"},{"key":"348_CR48","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1186\/1471-2164-7-315","volume":"7","author":"AK Arakaki","year":"2006","unstructured":"Arakaki AK, Tian W, Skolnick J: High precision multi-genome scale reannotation of enzyme function by EFICAz. BMC genomics. 2006, 7: 315- 10.1186\/1471-2164-7-315","journal-title":"BMC genomics"},{"key":"348_CR49","unstructured":"Affymetrix Human Genome U133 Plus 2.0 Array - Support Materials. http:\/\/www.affymetrix.com\/support\/technical\/byproduct.affx?product=hg-u133-plus"},{"issue":"13","key":"348_CR50","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/bioinformatics\/bth199","volume":"20","author":"AB Horne","year":"2004","unstructured":"Horne AB, Hodgman TC, Spence HD, Dalby AR: Constructing an enzyme-centric view of metabolism. Bioinformatics. 2004, 20 (13): 2050-2055. 10.1093\/bioinformatics\/bth199","journal-title":"Bioinformatics"},{"key":"348_CR51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/0076-6879(92)09025-X","volume":"209","author":"F Snyder","year":"1992","unstructured":"Snyder F: Alkylglycerol phosphotransferase. Methods Enzymol. 1992, 209: 211-215. 1992\/01\/01.","journal-title":"Methods Enzymol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-7-57.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T01:57:39Z","timestamp":1630461459000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-7-57"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,17]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["348"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-7-57","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,17]]},"assertion":[{"value":"2 January 2008","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2008","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2008","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"57"}}